Boston Type 1 Keratoprosthesis versus Repeat Donor Keratoplasty for Corneal Graft Failure: A Systematic Review and Meta-analysis

Ophthalmology

Volumn 123, Issue 1, 2016, Pages 165-177

  Ahmad, Sumayya ^a   Mathews, Priya M ^a   Lindsley, Kristina ^b   Alkharashi, Majed ^e   Hwang, Frank S ^d   Ng, Sueko M ^b   Aldave, Anthony J ^c   Akpek, Esen Karamursel ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARIBBEAN; COCHRANE LIBRARY; COHORT ANALYSIS; COMORBIDITY; CORNEA TRANSPLANTATION; GLAUCOMA; GRAFT FAILURE; HAND MOVEMENT; HUMAN; KERATOCONJUNCTIVITIS SICCA; KERATOPROSTHESIS; META ANALYSIS; OCULAR SURFACE DISEASE; OPHTHALMOLOGY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REPEAT DONOR KERATOPLASTY; SYSTEMATIC REVIEW; TERTIARY CARE CENTER; TERTIARY HEALTH CARE; UNITED STATES; VISUAL ACUITY; ARTIFICIAL ORGAN; CORNEAL DISEASES; GRAFT REJECTION; GRAFT SURVIVAL; PROCEDURES; PROSTHESES AND ORTHOSES; REOPERATION;

ARTIFICIAL ORGANS; CORNEAL DISEASES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KERATOPLASTY, PENETRATING; PROSTHESES AND IMPLANTS; REOPERATION; VISUAL ACUITY;

EID: 84951196501     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.09.028     Document Type: Article

References (91)

1. Eye Bank Association of America. Eye Banking Statistical Report. Washington, D.C.: Eye Bank Association of America; 2014.
2. Patel SV, Hodge DO, Bourne WM. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. Am J Ophthalmol 2005;139:311-9.
3. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology 2001;108:461-9.
4. Claesson M, Armitage WJ. Clinical outcome of repeat penetrating keratoplasty. Cornea 2013;32:1026-30.
5. Dandona L, Naduvilath TJ, Janarthanan M, et al. Survival analysis and visual outcome in a large series of corneal transplants in India. Br J Ophthalmol 1997;81: 726-31.
6. Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol 2008;43:165-9.
7. Khodadoust A. The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts. New York: Elsevier; 1973.
8. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113:1779.e1-e7.
9. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116:640-51.
10. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009;28: 989-96.
11. Ciolino JB, Belin MW, Todani A, et al. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013;120:1195-200.
12. Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011;118: 1543-50.
13. Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 2009;28:321-7.
14. Akpek EK, Alkharashi M, Hwang FS, et al. Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database Syst Rev 2014;11:CD009561.
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94.
16. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 2007;144:227-31.
17. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology 2012;119:1530-8.
18. Ament JD, Stryjewski TP, Ciolino JB, et al. Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol 2010;149: 221-228.e2.
19. Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: current techniques. Cornea 2006;25:656-62.
20. Crawford GJ, Hicks CR, Lou X, et al. The Chirila keratoprosthesis: phase I human clinical trial. Ophthalmology 2002;109:883-9.
21. Dunlap K, Chak G, Aquavella JV, et al. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology 2010;117:687-92.
22. Ghaffariyeh A, Honarpisheh N, Karkhaneh A, et al. Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Arch Clin Exp Ophthalmol 2011;249:93-101.
23. Guell JL, Arcos E, Gris O, et al. Outcomes with the Boston type 1 keratoprosthesis at Instituto de Microcirugia Ocular IMO. Saudi J Ophthalmol 2011;25:281-4.
24. Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea 2007;26:564-8.
25. Hicks CR, Crawford GJ, Lou X, et al. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye (Lond) 2003;17: 385-92.
26. Hicks CR, Crawford GJ, Tan DT, et al. Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea 2002;21: 685-90.
27. Hicks CR, Macvie O, Crawford GJ, Constable IJ. A risk score as part of an evidence-based approach to the selection of corneal replacement surgery. Cornea 2005;24:523-30.
28. Hille K, Hille A, Ruprecht KW. Medium term results in keratoprostheses with biocompatible and biological haptic. Graefes Arch Clin Exp Ophthalmol 2006;244:696-704.
29. Jiraskova N, Rozsival P, Burova M, Kalfertova M. AlphaCor artificial cornea: clinical outcome. Eye (Lond) 2011;25: 1138-46.
30. Kamyar R, Weizer JS, de Paula FH, et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea 2012;31:134-9.
31. Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007;47:61-71.
32. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119:484-9.
33. Patel AP, Wu EI, Ritterband DC, Seedor JA. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye (Lond) 2012;26:418-25.
34. Rudnisky CJ, Belin MW, Todani A, et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2012;119:951-5.
35. Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol 2008;145:438-44.
36. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea 2001;20:19-23.
37. Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 2013;33:532-41.
38. Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 2013;120: 2209-16.
39. Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea 2011;30:1187-94.
40. Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: the Dohlman-Doane device. Am J Ophthalmol 2005;140:1032-8.
41. Hicks CR, Crawford GJ, Dart JK, et al. AlphaCor: clinical outcomes. Cornea 2006;25:1034-42.
42. Verdejo-Gomez L, Pelaez N, Gris O, Guell JL. The Boston type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surg Lasers Imaging 2011;42:446-52.
43. Trichet E, Carles G, Matonti F, et al. [Alphacor keratoprosthesis: device, surgical technique and clinical outcomes]. J Fr Ophtalmol 2013;36:393-401.
44. Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in Jordan. Middle East Afr J Ophthalmol 2012;19: 97-100.
45. Shapiro BL, Cortes DE, Chin EK, et al. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea 2013;32:951-5.
46. Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea 2012;31:339-45.
47. Koller B, Neuhann T, Neuhann I. [Results with the Boston keratoprosthesis]. Ophthalmologe 2012;109:454-61.
48. Reeves B. Including non-randomized studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 510 (updated March 2011). The Cochrane Collaboration; 2011. Available at: www.cochranehandbook. org.
49. Schwarzer G. Meta-analysis with R. Vienna, Austria: The R Foundation for Statistical Computing; 2010:1-65.
50. Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology 2014;121:2159-64.
51. Schulze-Bonsel K, Feltgen N, Burau H, et al. Visual acuities "hand motion" and "counting fingers" can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006;47:1236-40.
52. Al-Mezaine H, Wagoner MD. Repeat penetrating keratoplasty: indications, graft survival, and visual outcome. Br J Ophthalmol 2006;90:324-7.
53. Borderie VM, Boelle PY, Touzeau O, et al. Predicted longterm outcome of corneal transplantation. Ophthalmology 2009;116:2354-60.
54. De Cock R. Penetrating keratoplasty in the West Bank and Gaza. Eye (Lond) 1994;8(Pt 1):29-34.
55. Fasolo A, Capuzzo C, Fornea M, et al. Risk factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study. Cornea 2011;30: 1328-35.
56. Hayashi K, Kondo H, Maeno A, Takimoto M. Long-term changes in corneal endothelial cell density after repeat penetrating keratoplasty in eyes with endothelial decompensation. Cornea 2013;32:1019-25.
57. Joshi SA, Jagdale SS, More PD, Deshpande M. Outcome of optical penetrating keratoplasties at a tertiary care eye institute in Western India. Indian J Ophthalmol 2012;60:15-21.
58. Kelly TL, Coster DJ, Williams KA. Repeat penetrating corneal transplantation in patients with keratoconus. Ophthalmology 2011;118:1538-42.
59. Kirkness CM, Ezra E, Rice NS, Steele AD. The success and survival of repeat corneal grafts. Eye (Lond) 1990;4(Pt 1): 58-64.
60. Parmar P, Salman A, Kalavathy CM, et al. Outcome analysis of cataract surgery following therapeutic keratoplasty. Cornea 2005;24:123-9.
61. Patel HY, Ormonde S, Brookes NH, et al. The New Zealand National Eye Bank: survival and visual outcome 1 year after penetrating keratoplasty. Cornea 2011;30:760-4.
62. Patel NP, Kim T, Rapuano CJ, et al. Indications for and outcomes of repeat penetrating keratoplasty, 1989e1995. Ophthalmology 2000;107:719-24.
63. Rahman I, Carley F, Hillarby C, et al. Penetrating keratoplasty: indications, outcomes, and complications. Eye (Lond) 2009;23:1288-94.
64. Randleman JB, Song CD, Palay DA. Indications for and outcomes of penetrating keratoplasty performed by resident surgeons. Am J Ophthalmol 2003;136:68-75.
65. Rapuano CJ, Cohen EJ, Brady SE, et al. Indications for and outcomes of repeat penetrating keratoplasty. Am J Ophthalmol 1990;109:689-95.
66. Sellami D, Abid S, Bouaouaja G, et al. Epidemiology and risk factors for corneal graft rejection. Transplant Proc 2007;39: 2609-11.
67. Tan DT, Janardhanan P, Zhou H, et al. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. Ophthalmology 2008;115:975-982.e1.
68. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Longterm graft survival after penetrating keratoplasty. Ophthalmology 2003;110:1396-402.
69. Vanathi M, Sharma N, Sinha R, et al. Indications and outcome of repeat penetrating keratoplasty in India. BMC Ophthalmol 2005;5:26.
70. Weisbrod DJ, Sit M, Naor J, Slomovic AR. Outcomes of repeat penetrating keratoplasty and risk factors for graft failure. Cornea 2003;22:429-34.
71. Williams KA, Lowe M, Bartlett C, et al. Risk factors for human corneal graft failure within the Australian corneal graft registry. Transplantation 2008;86:1720-4.
72. Yalniz-Akkaya Z, Burcu Nurozler A, Yildiz E, et al. Repeat penetrating keratoplasty: indications and prognosis, 1995e2005. Eur J Ophthalmol 2009;19:362-8.
73. Yamagami S, Suzuki Y, Tsuru T. Risk factors for graft failure in penetrating keratoplasty. Acta Ophthalmol Scand 1996;74: 584-8.
74. Yildiz EH, Hoskins E, Fram N, et al. Third or greater penetrating keratoplasties: indications, survival, and visual outcomes. Cornea 2010;29:254-9.
75. Beckingsale P, Mavrikakis I, Al-Yousuf N, et al. Penetrating keratoplasty: outcomes from a corneal unit compared to national data. Br J Ophthalmol 2006;90:728-31.
76. Inoue K, Amano S, Oshika T, et al. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol 2000;44:139-45.
77. Inoue K, Amano S, Oshika T, Tsuru T. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand 2001;79:251-5.
78. Yamagami S, Suzuki Y, Ohya T, et al. [Multivariate analysis of risk factors of rejection in penetrating keratoplasty]. Nihon Ganka Gakkai Zasshi 1994;98:1097-100.
79. Lee WB, Shtein RM, Kaufman SC, et al. Boston Keratoprosthesis: outcomes and complications. A report by the American Academy of Ophthalmology. Ophthalmology 2015;122:1504-11.
80. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994;101:1536-47.
81. Rumelt S, Bersudsky V, Blum-Hareuveni T, Rehany U. Preexisting and postoperative glaucoma in repeated corneal transplantation. Cornea 2002;21:759-65.
82. Goldberg DB, Schanzlin DJ, Brown SI. Incidence of increased intraocular pressure after keratoplasty. Am J Ophthalmol 1981;92:372-7.
83. Polack FM. Glaucoma in keratoplasty. Cornea 1988;7:67-70.
84. Simmons RB, Stern RA, Teekhasaenee C, Kenyon KR. Elevated intraocular pressure following penetrating keratoplasty. Trans Am Ophthalmol Soc 1989;87:79-91. discussion 91e3.
85. Ahmad S, Akpek EK, Gehlbach PL, et al. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation. Am J Ophthalmol 2014;159:739-47.
86. Crnej A, Paschalis EI, Salvador-Culla B, et al. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea 2014;33:349-54.
87. Huh ES, Aref AA, Vajaranant TS, et al. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery. J Glaucoma 2014;23:e39-44.
88. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 2012;96:776-80.
89. Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol 2005;16:246-50.
90. Traish AS, Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol 2010;25:239-43.
91. HarissieDagher M. Boston keratoprosthesis: expanding the boundaries. Digit J Ophthalmol 2011;17:53-4.